Myomo Inc

MYO is in a Stage 4 decline, forming clear lower highs and lower lows under declining EMAs. Price is holding around the 9EMA/20EMA zone with no exhaustion or mean-reversion signals, and volume favors downside continuation. Both short-term and medium-term biases are bearish, and timing conditions support immediate participation at resistance around the short EMAs. The long-term downtrend is confirmed by a declining 200-day SMA. Only a sustained reclaim and close above the 20EMA would invalidate this bearish posture.

• ↑Fair value estimate climbed from $1.10 to $1.70 on expected margin improvements.
• ↑Q3 earnings projections upgraded, reflecting better operational outlook.
• ↓Earnings yield is deeply negative, highlighting poor return potential.